Related Experiment Video
Updated: Dec 18, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.7K
The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication
Laura MacDonald1, Jonathan Jenkins1, Grace Purvis2
1Department of Biology, Hendrix College, Conway, AR, USA.
Hormones & Cancer
|June 18, 2020
Summary
Rising thyroid cancer incidence necessitates understanding tumor progression. The tumor microenvironment plays a key role in thyroid cancer development and treatment resistance, requiring further research.
Area of Science:
- Endocrinology
- Oncology
- Cancer Biology
Background:
- Thyroid cancer is the most common endocrine malignancy with increasing incidence.
- While many thyroid tumors are treatable, persistent disease and advanced types like anaplastic thyroid cancer have poor prognoses.
- Current treatments can lead to significant patient morbidity.
Purpose of the Study:
- To review the current understanding of the thyroid tumor microenvironment (TME).
- To explore how TME components influence thyroid tumor progression and therapeutic resistance.
- To highlight the need for further research into the TME's role in thyroid cancer pathogenesis.
Main Methods:
- Literature review of existing studies on the thyroid tumor microenvironment.
- Analysis of the role of stromal cells and extracellular matrix in thyroid cancer.
- Synthesis of current knowledge on cell-cell interactions within the thyroid tumor niche.
Main Results:
- The tumor microenvironment, including stromal cells, is increasingly recognized for its role in driving tumor progression.
- Components of the TME can contribute to resistance to standard thyroid cancer therapies.
- Understanding the TME is crucial for identifying patients at risk of aggressive disease.
Conclusions:
- The thyroid tumor microenvironment is a critical factor in thyroid cancer pathogenesis and treatment outcomes.
- Further investigation is needed to elucidate the complex interactions within the thyroid TME.
- Targeting the TME may offer new therapeutic strategies and reduce treatment morbidity.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K

